StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
300261.SZ$4.99-3.48%
Fair $4.99+0.0%

300261.SZ

ABA Chemicals Corporation

Basic Materials / ChemicalsShenzhen

$4.99

-0.18 (-3.48%)

Fairly Valued+0.0%Fair Value $4.99Fund rank 26/100 · Data gapFallback financials|
SA 10/F
F-Score: 6/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 18%

FCF escenarios

weak_data · normalized FCF $-128.4M · quality 43.7/100

Data gap 26/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 15/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

10/100

F

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists. ROE is -8.5%, below the 5% threshold
Thesis & Journal · 300261.SZLocal privado en este navegador · ABA Chemicals Corporation
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$4.8B

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-8.5%

↓

Gross Margin

18.4%

↓

Debt/Equity

0.65

↑
52-Week Range$5
$5$9

TradingView lightweight chart

300261.SZ price, volumen y niveles de valoración

Último $4.990Periodo +56.8%
Fair value: $4.990

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-13.2%

FCF CAGR

—

FCF margin

-9.8%

FCF / Net income

0.80x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.31B · net income $-159.5M · FCF $-128.4M

2022-FY → 2025-FY

Gross margin

18.4%-12.6% pts

Operating margin

-3.8%-17.9% pts

Net margin

-12.2%-22.3% pts

FCF margin

-9.8%-4.4% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.31B$1.31B$1.20B$1.28B$2.00B
Net Income$-159.5M$-159.5M$-257.7M$-82.3M$202.9M
EBITDA$-12.8M$-12.8M$-134.3M$84.2M$418.9M
EPS-0.17-0.17-0.27-0.090.21
Gross Margin18.4%18.4%15.1%23.5%31.0%
Operating Margin-3.8%-3.8%-10.7%-2.1%14.1%
Net Margin-12.2%-12.2%-21.4%-6.4%10.1%
Balance Sheet
Debt/Equity0.650.650.610.480.37
Current Ratio0.850.85———
Cash Flow
Free Cash Flow$-128.4M$-128.4M$57.5M$-258.1M$-108.9M
Returns
ROE-8.5%-8.5%-12.8%-3.6%8.5%
Valuation
P/E————54.61
EV/EBITDA———93.4727.46
P/B2.542.543.063.104.64
Growth & Yield
Revenue Growth8.7%8.7%-6.0%-36.1%—
EPS Growth38.2%38.2%-213.1%-140.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -30.0%

Total return

-30.0%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.27 → -0.17

Residual

-30.0%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term-30.0%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.